课题基金 / 基金详情

Understanding how BH3-only proteins initiate apoptosis in response to chemotherapy

Understanding how BH3-only proteins initiate apoptosis in response to chemotherapy
了解 BH3-only 蛋白如何启动化疗响应细胞凋亡
批准号:
nhmrc : 1078924
负责人:
A/Pr Grant Dewson
金额:
$32.08万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 2017-12-31

项目摘要

项目成果

A/Pr Grant Dewson的其他基金

相似基金

相关文献

中文摘要
翻译
未能启动细胞死亡是大多数癌症发展的一个标志,杀死所有肿瘤细胞对于有效的癌症治疗至关重要。一组被称为BH3-only蛋白的蛋白质通常会感知细胞应激,从而引发细胞死亡。它们的失调会导致癌症和化疗无效。了解这些蛋白质是如何诱导细胞死亡的,将有助于设计出模仿这种活性的药物,以改善癌症治疗。
英文摘要
Failure to initiate cell death is a hallmark in the development of the majority of cancers and killing all tumour cells is essential for effective cancer treatment. A group of proteins termed the BH3-only proteins normally sense cell stress to trigger cell death. Their dysregulation contributes to cancer and failure to respond to chemotherapy. Understanding how these proteins function to induce cell death will allow the design of drugs that mimic this activity for improved cancer therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding how Bcl-2 proteins form the apoptotic pores that kill cells
  • 批准号:
    nhmrc : GNT1141874
  • 项目类别:
    Project Grants
  • 资助金额:
    $89.36万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Grant Dewson
  • 依托单位:
Understanding how Bcl-2 proteins form the apoptotic pores that kill cells
Role of Bak and Bax membrane anchors in targeting and apoptotic pore formation.
Deciphering activation of the apoptotic cell death program
海外基金